Pricing Log in Create free account

Prelude Therapeutics Incorporated (PRLD) vs Rocket Pharmaceuticals, Inc. (RCKT)

Prelude Therapeutics Incorporated and Rocket Pharmaceuticals, Inc. are both Biotechnology companies. Prelude Therapeutics Incorporated and Rocket Pharmaceuticals, Inc. are of similar size ($265.0M and $259.1M). Rocket Pharmaceuticals, Inc. has the higher net margin (0.00% vs −269.8%) and the lower return on invested capital (−114.7% vs 0.00%). Across the 14 metrics below, Rocket Pharmaceuticals, Inc. leads on 10 and Prelude Therapeutics Incorporated on 4.

Valuation

Metric PRLD RCKT Biotechnology median
P/E n/m n/m 8.50
P/S 14.30 n/m 9.71
P/B 2.40 0.67 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.07 0.64
EV/Sales 7.54 n/m 9.21
Earnings yield (22.39%) (7.34%) (33.15%)
Free cash flow yield (10.39%) (69.93%) (25.50%)

Profitability

Metric PRLD RCKT Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (300.56%) 0.00% 0.00%
Net margin (269.75%) 0.00% 0.00%
Free cash flow margin (148.30%) 0.00% 0.00%
Return on equity (57.73%) (4.77%) (56.36%)
Return on assets (39.76%) (4.09%) (48.04%)
Return on invested capital 0.00% (114.71%) 0.00%

Growth

Metric PRLD RCKT Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 23.21% 26.37% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PRLD RCKT Biotechnology median
Debt to equity 0.00 0.05 0.00
Current ratio 4.07 9.24 4.72
Net debt to EBITDA 1.00 0.77 0.96

Dividend

Metric PRLD RCKT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric PRLD RCKT Biotechnology median
Market cap 264.95m 259.07m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack